## Abstract Human Wharton's jelly stem cells (HWJSC) emerged as a potential source of viable cells for use in tissue engineering. In this work, we have analyzed the transdifferentiation capabilities of HWJSC towards transdifferentiated endothelial‐like cells (Tr‐ELC) in order to establish the poten
Transplantation of human embryonic stem cell-derived endothelial cells for vascular diseases
✍ Scribed by Zongjin Li; Zhongchao Han; Joseph C. Wu
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 144 KB
- Volume
- 106
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Using endothelial cells for therapeutic angiogenesis/vasculogenesis of ischemia diseases has led to exploring human embryonic stem cells (hESCs) as a potentially unlimited source for endothelial progenitor cells. With their capacity for self‐renewal and pluripotency, hESCs and their derived endothelial cells (hESC‐ECs) may be more advantageous than other endothelial cells obtained from diseased populations. However, hESC‐ECs' poor differentiation efficiency and poorly characterized in vivo function after transplantation present significant challenges for their future clinical application. This review will focus on the differentiation pathways of hESCs and their therapeutic potential for vascular diseases, as well as the monitoring of transplanted cells' fate via molecular imaging. Finally, cell enhancement strategies to improve the engraftment efficiency of hESC‐ECs will be discussed. J. Cell. Biochem. 106: 194–199, 2009. © 2008 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
emerging Technology Platforms For Stem Cells the Latest In Applied Stem Cell Research adult And Embryonic Stem Cells Are Set To Play An Integral Part In The New Paradigm Of Personal Medicine And Genetic Therapies. However, Researchers Still Seek To Better Understand These Cells, Their Potential Us
emerging Technology Platforms For Stem Cells the Latest In Applied Stem Cell Research adult And Embryonic Stem Cells Are Set To Play An Integral Part In The New Paradigm Of Personal Medicine And Genetic Therapies. However, Researchers Still Seek To Better Understand These Cells, Their Potential Us
## Abstract Cell therapies in animal models of neurobehavioral defects are normally derived from neural stem cells (NSC) of the developing cortex. However, the clinical feasibility of NSC therapies would be greatly improved by deriving transplanted cells and from a tissue culture source that is sel